
特点
配备了可在Windows上运行的GUI (图形用户界面),从参数的输入到模拟结果的显示都可以轻松操作。另外,还包含数据文件的保存/读取、图表的编辑、计算值和图表的打印输出、模拟结果和实测值的比较、多个数据的显示等各种功能。
模拟模型
*皮肤渗透模型(双层膜或单层膜)
*药物溶解基质制剂/皮肤渗透模型
*药物分散基质制剂/皮肤渗透模型
*药物隔室/皮肤渗透模型

参数输入
*制剂使用时间,使用面积
*制剂的药物释放特性(制剂内扩散系数、含量…)
*皮肤结构(角质层厚度,到皮肤血流的距离…)
*药物皮内扩散系数,分配系数
*体内动态参数(1,2,3隔室模型)
可选输入参数
*皮肤吸附相关参数( Langmuir/ Freundlich模型)
*皮肤代谢相关参数( Michaelis-Menten/一次反应式)
*离子电渗相关参数(电排斥: Nernst-Planck/电渗透)
*药效学( Pharmacodynamic )参数(直接反应模型/药效分区模型/间接反应模型)
输出数据
*累积透过量
*血药浓度
*皮内/制剂内药物浓度分布
*药效强度(输入PD参数时)
还可以分析反复给药结果和皮内/制剂内药物浓度的时间变化,对制剂设计有用。

应用
经皮给药制剂(TDDS)IVIVC体内外相关性研究,局部外用药的皮下渗透分布、护肤品的皮肤吸收预测等。
文献引用
1. Bird, D., Ravindra, N.M. (New Jersey Institute of Technology) Transdermal drug delivery and patches - An overview, Med. Devices Sens. 2020, 3, e10069.
2. Binarjo, A. ', Nugroho, A.K. (1 Ahmad Dahlan University, Universitas Gadjah Mada)Improvement of losartan transdermal permeation using oleic acid pretreatment: in vitro observation and in vivo prediction, Pharmaceutical Sciences and Research (PSR),2019, 6(1), 21-27.
3. Garg, A., Singh, S., Transdermal drug delivery systems, In: Misra, A., Shahiwala, A.eds. , In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes, CRC Press, 2018.
4. Miwa, Y. ', Hamamoto, H. ', Ishida, T.2 (1 MEDRx Co., Ltd., 2 Tokushima University) Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug Etodolac via its transformation into an ionic liquid, Eur. J. Pharm.Biopharm. 2016, 102, 92-100.
5. Ishida, M., Takeuchi, H., Endo, H., Yamaguchi, J. (Taisho Pharmaceutical Co., Ltd.) Impact of humidity on in vitro human skin permeation experiments for predicting in vivo permeability, J. Pharm. Sci. , 2015, 104(12), 4223-4231.
6. Olatunji, O.1; Das, D.B.1; Al-Qallaf, B.2 (1 Loughborough University, 2 Oxford University) Simulation based optimization of microneedle geometry to improve drug permeability in skin, 7th Annual Industrial Simulation Conference (ISC'2009), Loughborough, UK, June 1-3, 2009.